Pfizer Inc. (PFE)
USD 24.2
(1.13%)
USD 24.2
(1.13%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 61.53 Billion USD | 92.76% |
| 2022 | 31.92 Billion USD | -8.15% |
| 2021 | 34.75 Billion USD | -2.29% |
| 2020 | 35.57 Billion USD | -1.07% |
| 2019 | 35.95 Billion USD | 10.87% |
| 2018 | 32.42 Billion USD | -0.73% |
| 2017 | 32.66 Billion USD | 4.04% |
| 2016 | 31.39 Billion USD | 8.95% |
| 2015 | 28.81 Billion USD | -8.63% |
| 2014 | 31.54 Billion USD | 3.54% |
| 2013 | 30.46 Billion USD | -1.85% |
| 2012 | 31.03 Billion USD | -11.15% |
| 2011 | 34.93 Billion USD | -9.06% |
| 2010 | 38.41 Billion USD | -11.07% |
| 2009 | 43.19 Billion USD | 442.42% |
| 2008 | 7.96 Billion USD | 8.87% |
| 2007 | 7.31 Billion USD | 31.88% |
| 2006 | 5.54 Billion USD | -12.62% |
| 2005 | 6.34 Billion USD | -12.8% |
| 2004 | 7.27 Billion USD | 26.48% |
| 2003 | 5.75 Billion USD | 83.28% |
| 2002 | 3.14 Billion USD | 20.35% |
| 2001 | 2.6 Billion USD | 132.32% |
| 2000 | 1.12 Billion USD | 113.9% |
| 1999 | 525 Million USD | -0.38% |
| 1998 | 527 Million USD | -53.07% |
| 1997 | 1.12 Billion USD | 63.46% |
| 1996 | 687 Million USD | -17.53% |
| 1995 | 833 Million USD | 37.87% |
| 1994 | 604.2 Million USD | 5.91% |
| 1993 | 570.5 Million USD | -0.14% |
| 1992 | 571.3 Million USD | 44.05% |
| 1991 | 396.6 Million USD | 105.17% |
| 1990 | 193.3 Million USD | 1.42% |
| 1989 | 190.6 Million USD | -16.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 57.5 Billion USD | -6.2% |
| 2024 Q3 | 58 Billion USD | 0.86% |
| 2024 Q1 | 61.3 Billion USD | -0.38% |
| 2023 Q1 | 31.7 Billion USD | -0.69% |
| 2023 Q4 | 61.53 Billion USD | 0.8% |
| 2023 Q3 | 61.04 Billion USD | -0.5% |
| 2023 Q2 | 61.35 Billion USD | 93.53% |
| 2023 FY | 61.53 Billion USD | 92.76% |
| 2022 Q3 | 31.65 Billion USD | -7.7% |
| 2022 Q1 | 34.41 Billion USD | -0.98% |
| 2022 Q2 | 34.29 Billion USD | -0.35% |
| 2022 FY | 31.92 Billion USD | -8.15% |
| 2022 Q4 | 31.92 Billion USD | 0.86% |
| 2021 Q3 | 34.77 Billion USD | 2.75% |
| 2021 Q4 | 34.75 Billion USD | -0.06% |
| 2021 FY | 34.75 Billion USD | -2.29% |
| 2021 Q2 | 33.84 Billion USD | 0.03% |
| 2021 Q1 | 33.83 Billion USD | -4.88% |
| 2020 FY | 35.57 Billion USD | -1.07% |
| 2020 Q1 | 36.28 Billion USD | 0.91% |
| 2020 Q2 | 50.52 Billion USD | 39.27% |
| 2020 Q3 | 48.16 Billion USD | -4.68% |
| 2020 Q4 | 35.57 Billion USD | -26.15% |
| 2019 Q2 | 36.16 Billion USD | 1.22% |
| 2019 Q1 | 35.73 Billion USD | 10.19% |
| 2019 Q3 | 36.04 Billion USD | -0.34% |
| 2019 Q4 | 35.95 Billion USD | -0.25% |
| 2019 FY | 35.95 Billion USD | 10.87% |
| 2018 Q2 | 28.93 Billion USD | -9.1% |
| 2018 Q3 | 33.65 Billion USD | 16.3% |
| 2018 Q4 | 32.42 Billion USD | -3.63% |
| 2018 FY | 32.42 Billion USD | -0.73% |
| 2018 Q1 | 31.83 Billion USD | -2.56% |
| 2017 Q3 | 34.5 Billion USD | 0.91% |
| 2017 Q2 | 34.19 Billion USD | -5.89% |
| 2017 FY | 32.66 Billion USD | 4.04% |
| 2017 Q1 | 36.33 Billion USD | 15.71% |
| 2017 Q4 | 32.66 Billion USD | -5.32% |
| 2016 Q2 | 30.45 Billion USD | 9.46% |
| 2016 FY | 31.39 Billion USD | 8.95% |
| 2016 Q1 | 27.82 Billion USD | -3.45% |
| 2016 Q3 | 30.43 Billion USD | -0.07% |
| 2016 Q4 | 31.39 Billion USD | 3.16% |
| 2015 FY | 28.81 Billion USD | -8.63% |
| 2015 Q1 | 29.37 Billion USD | -6.88% |
| 2015 Q3 | 29.07 Billion USD | 8.79% |
| 2015 Q4 | 28.81 Billion USD | -0.9% |
| 2015 Q2 | 26.72 Billion USD | -8.99% |
| 2014 Q4 | 31.54 Billion USD | -0.39% |
| 2014 Q3 | 31.66 Billion USD | -1.86% |
| 2014 Q2 | 32.26 Billion USD | 16.7% |
| 2014 FY | 31.54 Billion USD | 3.54% |
| 2014 Q1 | 27.64 Billion USD | -9.23% |
| 2013 Q2 | 31.53 Billion USD | 0.16% |
| 2013 FY | 30.46 Billion USD | -1.85% |
| 2013 Q3 | 31.81 Billion USD | 0.89% |
| 2013 Q4 | 30.46 Billion USD | -4.24% |
| 2013 Q1 | 31.48 Billion USD | 1.43% |
| 2012 FY | 31.03 Billion USD | -11.15% |
| 2012 Q4 | 31.03 Billion USD | -0.15% |
| 2012 Q3 | 31.08 Billion USD | 0.7% |
| 2012 Q1 | 33.54 Billion USD | -3.97% |
| 2012 Q2 | 30.86 Billion USD | -7.97% |
| 2011 FY | 34.93 Billion USD | -9.06% |
| 2011 Q3 | 35.39 Billion USD | -0.91% |
| 2011 Q2 | 35.72 Billion USD | 1.18% |
| 2011 Q1 | 35.3 Billion USD | -8.08% |
| 2011 Q4 | 34.93 Billion USD | -1.32% |
| 2010 Q1 | 38.28 Billion USD | -11.37% |
| 2010 FY | 38.41 Billion USD | -11.07% |
| 2010 Q4 | 38.41 Billion USD | -1.54% |
| 2010 Q3 | 39.01 Billion USD | 3.3% |
| 2010 Q2 | 37.76 Billion USD | -1.35% |
| 2009 Q2 | 38.89 Billion USD | 39.73% |
| 2009 Q1 | 27.83 Billion USD | 249.54% |
| 2009 FY | 43.19 Billion USD | 442.42% |
| 2009 Q3 | 39.24 Billion USD | 0.91% |
| 2009 Q4 | 43.19 Billion USD | 10.06% |
| 2008 Q3 | 7.15 Billion USD | -1.3% |
| 2008 Q1 | 8.14 Billion USD | 11.33% |
| 2008 Q2 | 7.24 Billion USD | -11.02% |
| 2008 FY | 7.96 Billion USD | 8.87% |
| 2008 Q4 | 7.96 Billion USD | 11.34% |
| 2007 Q2 | 5.77 Billion USD | 21.09% |
| 2007 Q4 | 7.31 Billion USD | 21.07% |
| 2007 FY | 7.31 Billion USD | 31.88% |
| 2007 Q1 | 4.77 Billion USD | -13.97% |
| 2007 Q3 | 6.04 Billion USD | 4.57% |
| 2006 Q4 | 5.54 Billion USD | -0.27% |
| 2006 FY | 5.54 Billion USD | -12.62% |
| 2006 Q1 | 6.5 Billion USD | 2.54% |
| 2006 Q2 | 5.45 Billion USD | -16.26% |
| 2006 Q3 | 5.56 Billion USD | 2.04% |
| 2005 Q2 | 5.51 Billion USD | -14.23% |
| 2005 Q1 | 6.43 Billion USD | -11.64% |
| 2005 FY | 6.34 Billion USD | -12.8% |
| 2005 Q4 | 6.34 Billion USD | 17.23% |
| 2005 Q3 | 5.41 Billion USD | -1.87% |
| 2004 Q2 | 6.76 Billion USD | -5.31% |
| 2004 Q4 | 7.27 Billion USD | -8.51% |
| 2004 Q1 | 7.14 Billion USD | 24.14% |
| 2004 FY | 7.27 Billion USD | 26.48% |
| 2004 Q3 | 7.95 Billion USD | 17.61% |
| 2003 Q3 | 6.43 Billion USD | -4.04% |
| 2003 FY | 5.75 Billion USD | 83.28% |
| 2003 Q1 | 3.71 Billion USD | 18.25% |
| 2003 Q2 | 6.71 Billion USD | 80.72% |
| 2003 Q4 | 5.75 Billion USD | -10.62% |
| 2002 Q4 | 3.14 Billion USD | 0.71% |
| 2002 Q3 | 3.11 Billion USD | 1.5% |
| 2002 Q2 | 3.07 Billion USD | 19.07% |
| 2002 Q1 | 2.58 Billion USD | -1.11% |
| 2002 FY | 3.14 Billion USD | 20.35% |
| 2001 Q1 | 1.88 Billion USD | 68.12% |
| 2001 Q2 | 2.36 Billion USD | 25.37% |
| 2001 Q4 | 2.6 Billion USD | 25.01% |
| 2001 Q3 | 2.08 Billion USD | -11.83% |
| 2001 FY | 2.6 Billion USD | 132.32% |
| 2000 Q2 | 1.26 Billion USD | 141.6% |
| 2000 FY | 1.12 Billion USD | 113.9% |
| 2000 Q4 | 1.12 Billion USD | -10.66% |
| 2000 Q3 | 1.25 Billion USD | -0.71% |
| 2000 Q1 | 524 Million USD | -0.19% |
| 1999 Q2 | 530 Million USD | 0.95% |
| 1999 Q4 | 525 Million USD | 0.0% |
| 1999 FY | 525 Million USD | -0.38% |
| 1999 Q1 | 525 Million USD | -0.38% |
| 1999 Q3 | 525 Million USD | -0.94% |
| 1998 Q3 | 528 Million USD | -27.07% |
| 1998 FY | 527 Million USD | -53.07% |
| 1998 Q1 | 729 Million USD | -35.08% |
| 1998 Q2 | 724 Million USD | -0.69% |
| 1998 Q4 | 527 Million USD | -0.19% |
| 1997 Q4 | 1.12 Billion USD | 54.05% |
| 1997 Q1 | 732 Million USD | 6.55% |
| 1997 Q2 | 731 Million USD | -0.14% |
| 1997 Q3 | 729 Million USD | -0.27% |
| 1997 FY | 1.12 Billion USD | 63.46% |
| 1996 Q4 | 687 Million USD | 24.23% |
| 1996 Q3 | 553 Million USD | -5.15% |
| 1996 Q2 | 583 Million USD | -0.17% |
| 1996 FY | 687 Million USD | -17.53% |
| 1996 Q1 | 584 Million USD | -29.89% |
| 1995 Q2 | 611.2 Million USD | 0.21% |
| 1995 FY | 833 Million USD | 37.87% |
| 1995 Q1 | 609.9 Million USD | 0.94% |
| 1995 Q3 | 358.2 Million USD | -41.39% |
| 1995 Q4 | 833 Million USD | 132.55% |
| 1994 Q1 | 570.1 Million USD | -0.07% |
| 1994 Q2 | 570.2 Million USD | 0.02% |
| 1994 Q4 | 604.2 Million USD | 3.05% |
| 1994 FY | 604.2 Million USD | 5.91% |
| 1994 Q3 | 586.3 Million USD | 2.82% |
| 1993 Q4 | 570.5 Million USD | -0.42% |
| 1993 Q2 | 574.4 Million USD | 0.14% |
| 1993 FY | 570.5 Million USD | -0.14% |
| 1993 Q1 | 573.6 Million USD | 0.4% |
| 1993 Q3 | 572.9 Million USD | -0.26% |
| 1992 Q3 | 591.6 Million USD | 1.82% |
| 1992 Q1 | 579.8 Million USD | 46.19% |
| 1992 Q2 | 581 Million USD | 0.21% |
| 1992 Q4 | 571.3 Million USD | -3.43% |
| 1992 FY | 571.3 Million USD | 44.05% |
| 1991 Q4 | 396.6 Million USD | 166.35% |
| 1991 FY | 396.6 Million USD | 105.17% |
| 1991 Q1 | 177.2 Million USD | -8.33% |
| 1991 Q2 | 157.2 Million USD | -11.29% |
| 1991 Q3 | 148.9 Million USD | -5.28% |
| 1990 Q1 | 189.6 Million USD | -0.52% |
| 1990 Q4 | 193.3 Million USD | 1.79% |
| 1990 Q2 | 181.8 Million USD | -4.11% |
| 1990 FY | 193.3 Million USD | 1.42% |
| 1990 Q3 | 189.9 Million USD | 4.46% |
| 1989 FY | 190.6 Million USD | -16.0% |
| 1989 Q4 | 190.6 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbbVie Inc. | 52.19 Billion USD | -17.902% |
| Bristol-Myers Squibb Company | 38.18 Billion USD | -61.166% |
| Bristol-Myers Squibb Company Ce | 38.18 Billion USD | -61.166% |
| Johnson & Johnson | 25.88 Billion USD | -137.773% |
| Eli Lilly and Company | 18.32 Billion USD | -235.891% |
| Merck & Co., Inc. | 33.68 Billion USD | -82.698% |
| Novartis AG | 20.03 Billion USD | -207.168% |
| Organon & Co. | 8.75 Billion USD | -603.211% |